Company patents
ElectroCore, Inc.
ElectroCore, Inc. exhibits a highly concentrated patent strategy, with 87.3% of its portfolio in Electrotherapy / Radiation Therapy, yet this core area has seen a significant decline in new patent filings, dropping by 30.4% in 2025 and 62.5% so far in 2026. Surprisingly, despite being a medical device company, ElectroCore also holds patents in diverse, seemingly unrelated areas like Business Methods & Fintech (13.9% of portfolio) and Data Recognition (Barcodes, OCR) (12.7% of portfolio), both of which have seen a complete cessation of new filings so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
79 US filings (since 2023) · 9 categories · 4 themes
Therapeutic application of electrical signals to nerves or tissues to modulate their activity, often using implantable devices, electrodes, and sophisticated programming for various conditions.
Systems that provide therapeutic stimulation or field therapy through wearable devices, often incorporating physiological sensing and closed-loop feedback for personalized and adaptive treatment.
Use of alternating electric or magnetic fields at specific frequencies and intensities to achieve therapeutic effects, such as inhibiting cell proliferation (e.g., cancer) or modulating cytokine production.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Patents
Showing 1-10 of 135